China Pharma Holdings (CPHI) FCF Margin Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.16 Bn | 43.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.86 Bn | 40.20 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 32.53 Bn | 30.86 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | China Pharma Holdings | 42.18 Mn | 41.88 Mn | 83,566.00 | -3,021.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 600.00 |
| Dec 31, 2025 | -1,226.00 |
| Sep 30, 2025 | -2,799.00 |
| Jun 30, 2025 | 3,779.00 |
| Mar 31, 2025 | 3,110.00 |
| Dec 31, 2024 | 2,587.00 |
| Sep 30, 2024 | -5,554.00 |
| Jun 30, 2024 | 1,144.00 |
| Mar 31, 2024 | 2,933.00 |
| Dec 31, 2023 | -2,220.00 |
| Sep 30, 2023 | 5,381.00 |
| Jun 30, 2023 | 1,226.00 |
| Mar 31, 2023 | -1,713.00 |
| Dec 31, 2022 | 2,805.00 |
| Sep 30, 2022 | 4,211.00 |
| Jun 30, 2022 | -5,955.00 |
| Mar 31, 2022 | -4,317.00 |
| Dec 31, 2021 | -2,646.00 |
| Sep 30, 2021 | -2,366.00 |
| Jun 30, 2021 | 3,863.00 |